- Home
- HSCS vs PTIX Comparison
HSCS vs PTIX Comparison
Compare HSCS & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- PTIX
- Stock Information
- Founded
- HSCS 2007
- PTIX 1994
- Country
- HSCS United States
- PTIX United States
- Employees
- HSCS N/A
- PTIX N/A
- Industry
- HSCS Medical Specialities
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- PTIX Health Care
- Exchange
- HSCS Nasdaq
- PTIX Nasdaq
- Market Cap
- HSCS 3.7M
- PTIX 3.3M
- IPO Year
- HSCS 2022
- PTIX 2016
- Fundamental
- Price
- HSCS $3.87
- PTIX $3.83
- Analyst Decision
- HSCS Strong Buy
- PTIX
- Analyst Count
- HSCS 2
- PTIX 0
- Target Price
- HSCS $13.00
- PTIX N/A
- AVG Volume (30 Days)
- HSCS 68.9K
- PTIX 210.6K
- Earning Date
- HSCS 07-28-2025
- PTIX 08-13-2025
- Dividend Yield
- HSCS N/A
- PTIX N/A
- EPS Growth
- HSCS N/A
- PTIX N/A
- EPS
- HSCS N/A
- PTIX N/A
- Revenue
- HSCS N/A
- PTIX N/A
- Revenue This Year
- HSCS N/A
- PTIX N/A
- Revenue Next Year
- HSCS N/A
- PTIX N/A
- P/E Ratio
- HSCS N/A
- PTIX N/A
- Revenue Growth
- HSCS 261.17
- PTIX N/A
- 52 Week Low
- HSCS $2.36
- PTIX $2.35
- 52 Week High
- HSCS $5.77
- PTIX $15.54
- Technical
- Relative Strength Index (RSI)
- HSCS 52.06
- PTIX 53.21
- Support Level
- HSCS $3.66
- PTIX $3.55
- Resistance Level
- HSCS $4.03
- PTIX $3.97
- Average True Range (ATR)
- HSCS 0.30
- PTIX 0.23
- MACD
- HSCS 0.01
- PTIX 0.04
- Stochastic Oscillator
- HSCS 41.11
- PTIX 81.83
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.